المؤلفون: Di Costanzo F; Unit of Medical Oncology, Azienda Ospedaliero Universitaria Careggi, Viale Pieraccini 17, 50139 Florence, Italy. dicostanzofrancesco@tiscali.it, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M, Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R

مؤلفون مشاركون: Italian Oncology Group for Cancer Research

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2008 Mar 19; Vol. 100 (6), pp. 388-98. Date of Electronic Publication: 2008 Mar 11.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Gastrectomy*/methods, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biomarkers, Tumor/*analysis , Stomach Neoplasms/*drug therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Diarrhea/chemically induced ; Disease-Free Survival ; Epirubicin/administration & dosage ; Female ; Fluorouracil/administration & dosage ; Hematologic Diseases/chemically induced ; Humans ; Immunohistochemistry ; Italy ; Kaplan-Meier Estimate ; Leucovorin/administration & dosage ; Lymph Node Excision ; Lymphatic Metastasis ; Male ; Middle Aged ; Mucositis/chemically induced ; Neoplasm Staging ; Patient Compliance ; Prognosis ; Proportional Hazards Models ; Stomach Neoplasms/chemistry ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Treatment Outcome ; Vomiting/chemically induced

SCR Protocol: FLEP protocol

المؤلفون: Labianca R; Unità Operativa di Oncologia Medica, Ospedali Riuniti, Bergamo, Italy (RL)., Fossati R, Zaniboni A, Torri V, Marsoni S, Nitti D, Boffi L, Scatizzi M, Tardio B, Mastrodonato N, Banducci S, Consani G, Pancera G

مؤلفون مشاركون: ACOI/GIVIO/GISCAD Investigators

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2004 May 19; Vol. 96 (10), pp. 750-8.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Portal Vein*, Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Colonic Neoplasms/*drug therapy, Adenocarcinoma/surgery ; Administration, Oral ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Colonic Neoplasms/surgery ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Fluorouracil/administration & dosage ; Humans ; Infusions, Intravenous ; Italy ; Leucovorin/administration & dosage ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Prognosis ; Research Design ; Risk Factors ; Survival Analysis ; Treatment Outcome

المؤلفون: Scagliotti GV; University of Torino, Department of Clinical and Biological Sciences, S. Luigi Hospital, Thoracic Oncology Unit, Orbassano, Torino, Italy. giorgio.scagliotti@unito.it, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M

مؤلفون مشاركون: Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2003 Oct 01; Vol. 95 (19), pp. 1453-61.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Carcinoma, Non-Small-Cell Lung/*surgery , Lung Neoplasms/*drug therapy , Lung Neoplasms/*surgery, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor/analysis ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Disease Progression ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Humans ; Italy ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Mitomycin/administration & dosage ; Multivariate Analysis ; Neoplasm Staging ; Odds Ratio ; Patient Compliance ; Patient Selection ; Proportional Hazards Models ; Prospective Studies ; Survival Analysis ; Treatment Outcome ; Vindesine/administration & dosage

المؤلفون: Bedognetti D; Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA. bedodav@yahoo.it, Sertoli MR, Pronzato P, Del Mastro L, Venturini M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 Oct 19; Vol. 103 (20), pp. 1529-39. Date of Electronic Publication: 2011 Sep 15.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Breast Neoplasms/*drug therapy, Adult ; Axilla ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Chemotherapy, Adjuvant ; Confounding Factors, Epidemiologic ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Drug Administration Schedule ; Epirubicin/administration & dosage ; Epirubicin/analogs & derivatives ; Female ; Fluorouracil/administration & dosage ; Follow-Up Studies ; Glucuronates/administration & dosage ; Humans ; Italy ; Kaplan-Meier Estimate ; Lymph Node Excision ; Mastectomy, Segmental ; Methotrexate/administration & dosage ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Neoplasms, Hormone-Dependent/drug therapy ; Prognosis ; Proportional Hazards Models ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Risk Factors ; Tamoxifen/administration & dosage ; Treatment Outcome

المؤلفون: Russo A, Autelitano M, Bisanti L

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2006 Dec 20; Vol. 98 (24), pp. 1826-7.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Hospital Costs*, Antineoplastic Agents/*adverse effects , Antineoplastic Agents/*economics , Breast Neoplasms/*drug therapy , Patient Admission/*economics, Aged ; Anemia/chemically induced ; Anemia/economics ; Breast Neoplasms/economics ; Female ; Fever/economics ; Fever/etiology ; Health Care Costs ; Humans ; Infections/economics ; Infections/etiology ; Italy ; Middle Aged ; Neutropenia/chemically induced ; Neutropenia/economics ; Population Surveillance ; Thrombocytopenia/chemically induced ; Thrombocytopenia/economics

المؤلفون: Venturini M; Institution of Oncologia Medica, Sperimentazioni Cliniche Controllate Istituto Nazionale per la Ricerca sul Cancro, Genova (PB), Italy. marco.venturini@istge.it, Del Mastro L, Aitini E, Baldini E, Caroti C, Contu A, Testore F, Brema F, Pronzato P, Cavazzini G, Sertoli MR, Canavese G, Rosso R, Bruzzi P

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2005 Dec 07; Vol. 97 (23), pp. 1724-33.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Breast Neoplasms/*drug therapy, Adult ; Aged ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant ; Confidence Intervals ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Epirubicin/administration & dosage ; Epirubicin/adverse effects ; Female ; Filgrastim ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Granulocyte Colony-Stimulating Factor/administration & dosage ; Humans ; Infusions, Intravenous ; Italy ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Recombinant Proteins ; Risk Factors ; Survival Analysis ; Treatment Outcome

SCR Protocol: FEC protocol

المؤلفون: Veronesi U; Scientific Directorate, European Institute of Oncology, Milan, Italy. umberto.veronesi@ieo.it, Maisonneuve P, Rotmensz N, Bonanni B, Boyle P, Viale G, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Oliviero P, Lovison F, Gucciardo G, del Turco MR, Muraca MG, Pizzichetta MA, Conforti S, Decensi A

مؤلفون مشاركون: Italian Tamoxifen Study Group

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2007 May 02; Vol. 99 (9), pp. 727-37.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Hysterectomy*, Breast Neoplasms/*prevention & control , Tamoxifen/*therapeutic use, Adult ; Aged ; Antineoplastic Agents, Hormonal/therapeutic use ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Italy/epidemiology ; Middle Aged ; Ovariectomy ; Placebos ; Risk Assessment ; Tamoxifen/adverse effects ; Time Factors

المؤلفون: Johnson BE

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2003 Oct 01; Vol. 95 (19), pp. 1422-4.

نوع المنشور: Comment; Editorial; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy, Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/surgery ; Chemotherapy, Adjuvant ; Humans ; Italy ; Lung Neoplasms/pathology ; Lung Neoplasms/surgery ; Multicenter Studies as Topic ; Neoplasm Staging ; Randomized Controlled Trials as Topic ; Survival Analysis ; Treatment Outcome

المؤلفون: Narasimhadevara R, Pollak MN, Foulkes WD

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2003 Jun 18; Vol. 95 (12), pp. 917; author reply 918-9.

نوع المنشور: Comment; Letter

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Hysterectomy*, Antineoplastic Agents, Hormonal/*therapeutic use , Breast Neoplasms/*prevention & control , Estrogen Receptor Modulators/*therapeutic use , Neoplasms, Hormone-Dependent/*prevention & control , Tamoxifen/*therapeutic use, Breast Neoplasms/epidemiology ; Female ; Humans ; Italy/epidemiology ; Mass Screening ; Neoplasms, Hormone-Dependent/epidemiology ; Randomized Controlled Trials as Topic ; Receptors, Estrogen/analysis ; Risk Factors

المؤلفون: Ménard S, Casalini P, Tagliabue E, Pupa SM, Balsari A

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2003 Jun 18; Vol. 95 (12), pp. 917-8; author reply 918-9.

نوع المنشور: Comment; Letter

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Hysterectomy*, Anticarcinogenic Agents/*therapeutic use , Antineoplastic Agents, Hormonal/*therapeutic use , Breast Neoplasms/*prevention & control , Neoplasms, Hormone-Dependent/*prevention & control , Receptor, ErbB-2/*analysis , Tamoxifen/*therapeutic use, Breast Neoplasms/chemistry ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Italy/epidemiology ; Mass Screening ; Neoplasms, Hormone-Dependent/chemistry ; Randomized Controlled Trials as Topic ; Risk Factors ; Up-Regulation